BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15665740)

  • 1. Cost-effectiveness of therapeutic drug monitoring: a systematic review.
    Touw DJ; Neef C; Thomson AH; Vinks AA;
    Ther Drug Monit; 2005 Feb; 27(1):10-7. PubMed ID: 15665740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A framework for economic evaluation of therapeutic drug monitoring-guided dosing in oncology.
    Erku D; Schneider J; Scuffham P
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00862. PubMed ID: 34546005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension.
    Chung O; Vongpatanasin W; Bonaventura K; Lotan Y; Sohns C; Haverkamp W; Dorenkamp M
    J Hypertens; 2014 Dec; 32(12):2411-21; discussion 2421. PubMed ID: 25255395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis.
    van Lent-Evers NA; Mathôt RA; Geus WP; van Hout BA; Vinks AA
    Ther Drug Monit; 1999 Feb; 21(1):63-73. PubMed ID: 10051056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review.
    Martelli L; Olivera P; Roblin X; Attar A; Peyrin-Biroulet L
    J Gastroenterol; 2017 Jan; 52(1):19-25. PubMed ID: 27665099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost-effectiveness analysis of active TDM in elderly patients treated with aminoglycosides].
    Leon-Djian CB; Bourguignon L; Späth HM; Maire P
    Therapie; 2011; 66(5):445-52. PubMed ID: 22031689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic drug monitoring for antidepressant drug treatment.
    Ostad Haji E; Hiemke C; Pfuhlmann B
    Curr Pharm Des; 2012; 18(36):5818-27. PubMed ID: 22681162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic monitoring: analytic, pharmacokinetic and clinical aspects].
    Marquet P
    Acta Clin Belg; 1999; 53 Suppl 1():2-12. PubMed ID: 10216973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic drug monitoring: focus on conditions in Indonesia.
    Setiabudy R
    Acta Med Indones; 2011 Jul; 43(3):208-11. PubMed ID: 21979288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Level of evidence for therapeutic drug monitoring of aminoglycosides].
    Venisse N; Boulamery A;
    Therapie; 2011; 66(1):39-44. PubMed ID: 21466776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive review of economic evaluations of therapeutic drug monitoring interventions for cancer treatments.
    Vithanachchi DT; Maujean A; Downes MJ; Scuffham P
    Br J Clin Pharmacol; 2021 Feb; 87(2):271-283. PubMed ID: 32692416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate dosing of antiarrhythmic drugs in Japan requires therapeutic drug monitoring.
    Takada M; Goto T; Kotake T; Saito M; Kawato N; Nakai M; Gunji T; Shibakawa M
    J Clin Pharm Ther; 2005 Feb; 30(1):5-12. PubMed ID: 15658999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-Care Therapeutic Drug Monitoring for Precision Dosing of Immunosuppressive Drugs.
    Taddeo A; Prim D; Bojescu ED; Segura JM; Pfeifer ME
    J Appl Lab Med; 2020 Jul; 5(4):738-761. PubMed ID: 32533157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of aminoglycoside toxicity and its prevention through therapeutic drug monitoring.
    Slaughter RL; Cappelletty DM
    Pharmacoeconomics; 1998 Oct; 14(4):385-94. PubMed ID: 10344906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of antidepressants: cost implications and relevance to clinical practice.
    Burke MJ; Preskorn SH
    Clin Pharmacokinet; 1999 Aug; 37(2):147-65. PubMed ID: 10496302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is therapeutic drug monitoring (TDM) in paediatric patients necessary?].
    Prokopczyk J; Piekarczyk A; Kaminska E
    Med Wieku Rozwoj; 2001; 5(2):149-55. PubMed ID: 11679679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of therapeutic drug monitoring in pharmacoeconomics.
    Destache CJ
    Ther Drug Monit; 1993 Dec; 15(6):608-10. PubMed ID: 8122303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness analysis of serum vancomycin concentration monitoring in patients with hematologic malignancies.
    Fernández de Gatta MD; Calvo MV; Hernández JM; Caballero D; San Miguel JF; Domínguez-Gil A
    Clin Pharmacol Ther; 1996 Sep; 60(3):332-40. PubMed ID: 8841156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic drug monitoring in epileptology and psychiatry].
    Brandt C; Baumann P; Eckermann G; Hiemke C; May TW; Rambeck B; Pohlmann-Eden B
    Nervenarzt; 2008 Feb; 79(2):167-74. PubMed ID: 17701390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring in pregnancy.
    Matsui DM
    Ther Drug Monit; 2012 Oct; 34(5):507-11. PubMed ID: 22846897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.